Leprosy by Lokesh Patil .pptx

This presentation provides an in-depth understanding of Leprosy (Hansen’s Disease) — a chronic infectious disease caused by Mycobacterium leprae. 🧬 It explores its causative organism, pathophysiology, clinical features, diagnostic methods, and available treatments in detail.

The slides also highlight the global and national efforts toward leprosy elimination, including awareness programs, multi-drug therapy (MDT), and the role of healthcare professionals in reducing stigma and ensuring early detection.

Designed for students, healthcare workers, and public health enthusiasts, this presentation aims to promote awareness, empathy, and knowledge about this often-misunderstood disease. 💡

#Leprosy #HansenDisease #PublicHealth #InfectiousDiseases #HealthcareAwareness #Pharmacy #WHO #LeprosyElimination #SlideShare

1. National Leprosy Control Programme Lokesh Patil, B. Ph- Final year

2. Introduction The National Leprosy Eradication Programme (NLEP), a centrally sponsored health scheme,  aims to eliminate leprosy in India through early detection, treatment, and disability prevention, with a focus on reducing the disease burden and improving public awareness .

3. 01 About the disease

4. Leprosy A chronic, curable infectious disease mainly causing skin lesions and nerve damage Leprosy is caused by Mycobacterium leprae. Transmission is via droplets from nose, mouth and during the close contact with untreated cases. Mainly affects skin, eyes, nerves (peripheral), nose. Leprosy is reported as majority cases from South- East Asia. Incubation period:- 5-7 years

5. Background Global registered prevalence:- 181,000 cases (2012) MDT came in wide use from:- 1982 National leprosy eradication program:- 1983 National Leprosy Control Program:- 1995

6. Milestones in NLEP 1948- Hind kusht Nivaran Sangh 1955- Govt. of India launched NLCP 1983- Launched NLEP and introduced MDT 1991- WHO declaration to eliminate leprosy at global level by 2000 Modified Leprosy elimination campaign 1993-2000 World bank supported NLEP 1 st

7. Milestones in NLEP 2001- 2004 World bank supported NLEP 2 nd 2005 National program continuous with GOI funds 2005- Indian achieved elimination of leprosy at national level December 05 Sponsored by central govt. Ministry / Dept:- DGHS Beneficiaries:- Individual and community Eligibility criteria anyone

8. Objectives of NLCP- 1955 Early Case detection. To provide domiciliary treatment to render infectious cases to non-infectious.

9. Objectives of NLEP- 1983 To detect cases of leprosy To treat all the cases of leprosy until its recovery Impart training to healthcare personnel Vision:- The attainment of leprosy free status for people of India To recommend grant in aid to various agencies engaged in anti-leprosy work To encourage research on various aspects of leprosy.

10. S t rategies of NLEP- 1983 Early case detection Short term Multi drug Therapy (MDT) Health education Rehabiliation services

11. Multi drug Thereapy Multibacillary Intensive Phase (lasting for 14 days) Rifampicin (600 mg) Clofazimine (300mg) Dapsone (100 mg) Continous phase (lasting for 2 years) Paucibacillary Rifampicin 600 mg once a month Dapsone 100 mg daily

12. Organization of NLEP Center level:- DGHS & NLEP officer State level:- DGHS & State NLEP officer Regional level:- Regional NLEP Officer

13. Indicators for evaluation and monitoring Proportion of suspected cases/ investigated outdoor patients Proportion of new cases / suspected cases Number of new cases detected Number of skin smears observed positive for lepra bacilli

14. Disability prevention and medical rehabilitation services Dressing materials, supportive medicines and ulcer kits Microcellular rubber footwear is provided for protection of insensitive feet NGOs in the country and 42 govt medical colleges An amount of Rs 5000 for leprosy affected persons to the family holding BPL card. Support also provided upto Rs 5000 for reconstructive surgery

15. Conclusion Leprosy is a curable and treatment provided in the early stages averts disability if MDT provided Control of leprosy has improved significantly as result of national and subnational campaigns in most endemic cases. Integration of basic leprosy services into general health service has made diagnosis and treatment more accessible.